Panitumumab, a fully human IgG2 anti-EGFR monoclonal antibody, exerts anti-tumor effects by inhibiting tumor cell proliferation, survival, and angiogenesis. It is utilized in researching various cancers, including colon cancer [1] [2] [4].
* VAT and and shipping costs not included. Errors and price changes excepted